Jersey City, NJ
GW Health, a strategic communications agency serving pharmaceutical, biotechnology, and life sciences organizations, today announced a partnership with VarsaAI, an AI-powered mechanism-of-action (MOA) and mechanism of disease (MOD) content platform designed for regulated healthcare communications.
Both companies share a conviction that AI has a specific and powerful role to play in pharmaceutical communications. Through this partnership, GW Health clients gain access to VarsaAI’s technology, which produces compliant, high-quality MOA and mechanism-of-disease content in minutes rather than weeks
“Life sciences companies are being asked to reach audiences faster, with greater complexity and higher stakes than ever before. VarsaAI gives us the technology to meet that demand, and GW Health brings the strategic and creative expertise to make it land.”
Mechanism-of-action content plays an important role in product education, disease awareness initiatives, scientific congress activities, and healthcare professional engagement. Traditionally, the development of these materials can involve multiple stakeholders and extended production timelines. VarsaAI’s platform is designed to streamline content creation through scientific verification tools, source referencing capabilities, and documentation features that support medical, legal, and regulatory review processes.
“What GW Health brings to this partnership is the strategic framework that allows VarsaAI to perform at its highest level. They understand how mechanism-of-action content lives within a broader launch story or disease education effort. The result for their clients is a faster path from scientific concept to compliant, audience-ready content than anything else on the market,” said Florence Holliday, Co-founder and Chief Science Officer of VarsaAI.
The companies stated that the partnership reflects a shared focus on advancing the responsible use of artificial intelligence within life sciences communications.
About GW Health
GW Health is a strategic communications agency serving pharmaceutical, biotechnology, and life sciences organizations across the product lifecycle. Founded by Aleisia Gibson Wright, the agency specializes in healthcare communications, scientific storytelling, corporate communications, and stakeholder engagement across multiple therapeutic areas.
About VarsaAI
VarsaAI is a technology company that develops AI-powered tools for pharmaceutical, biotechnology, and medical affairs teams. Its platform enables users to create mechanism-of-action presentations, videos, and related scientific communications materials while supporting documentation and review requirements commonly used in regulated healthcare environments.
Media Contact
Aleisia Gibson Wright
GW Health
917-405-0837
Last modified: June 29, 2026
